Improving outcome with CBTuhr: Costeffectiveness and profiling after 4-years

Helga Ising, Filip Smit, Stephan Ruhrmann, Wim Veling, Judith Rietdijk, Sara Dragt, Rianne Klaassen, Nynke Boonstra, Dorien Nieman, Lex Wunderink, Don Linszen, Mark Van Der Gaag



Aims: The first aim was to determine the cost-effectiveness of CBTuhr to prevent first-episode psychosis in ultra-high risk (UHR) at 18 and 48 months. The second aim was to develop an optimized prediction model of a first-episode psychosis. Methods: 196 help-seeking UHR patients participated in the Early Detection Intervention (EDIE) study in the Netherlands. All individuals were treated with routine care (RC) for non-psychotic disorders. The experimental group received add-on CBTuhr to prevent psychosis. Results: The CBTuhr intervention was cost saving at 18 and 48 months follow-up. This was achieved by less hospital admissions and a reduction in other service costs. Societal costs were reduced because more treated patients were employed. Prognostic modelling identified 3 UHR risk classes with 4%, 13% and 70% risk for transition within 18 months. In the highest risk class, transition to psychosis emerged on average ≥ 8 months earlier than in the lowest risk class. Conclusions: Using prognostic modelling and proactive care can accomplish health gain at lower costs.
Originele taal-2English
Aantal pagina's1
StatusPublished - 1-okt.-2016

Citeer dit